Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
An amendment to the Therapeutic Goods (Permissible Ingredients) Determination commenced on the Federal Register of Legislation (FRL) on 2 September 2019. The amendment determination is titled the Therapeutic Goods Amendment (Permissible Ingredients) Determination (No. 1) 2019. A total of 21 changes have been made in the updated Determination. These changes include:
- Addition of 3 new ingredient entries;
- Changes to 8 existing ingredient entries, including making requirements clearer and less restrictive; and
- Changes to caffeine and 9 caffeine containing ingredients to introduce more restrictive requirements following a safety review.
A complete list of changes to ingredients is below.
New ingredients
- 3,7-dimethyl-1-octen-3-ol
- Bacillus coagulans
- polyglyceryl-2 distearate
Changed ingredients
Ingredient | Reason for update |
---|---|
BRILLIANT SCARLET 4R | Less restrictive requirements |
BRILLIANT SCARLET 4R ALUMINIUM LAKE | Less restrictive requirements |
LAVANDULA ANGUSTIFOLIA | Correction of error, SUSMP alignment |
LAVANDULA ANGUSTIFOLIA SUBSP. ANGUSTIFOLIA | Correction of error, SUSMP alignment |
LAVANDULA X INTERMEDIA | Correction of error, SUSMP alignment |
LAVENDER OIL | Correction of error, SUSMP alignment |
ORIGANUM MAJORANA | Correction of error, SUSMP alignment |
THYMOL | Less restrictive requirements |
CAFFEINE | Safety review |
CAMELLIA SINENSIS | Safety review |
COFFEA ARABICA | Safety review |
COFFEA CANEPHORA | Safety review |
COFFEE | Safety review |
COLA ACUMINATA | Safety review |
COLA NITIDA | Safety review |
ILEX PARAGUARIENSIS | Safety review |
PAULLINIA CUPANA | Safety review |